Abstract
466 - Phase I study of ganetespib and ziv-aflibercept in patients with advanced gastrointestinal carcinomas, non-squamous non-small cell lung carcinomas, urothelial carcinomas, and sarcomas
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have